TrialBMC cancer2021

Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301).

Keisuke Miwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.